183 related articles for article (PubMed ID: 2833974)
1. Safety of surveillance in the management of stage I anaplastic germ cell tumours of the testis.
Crawford SM; Rustin GJ; Begent RH; Newlands ES; Bagshawe KD
Br J Urol; 1988 Mar; 61(3):250-3. PubMed ID: 2833974
[TBL] [Abstract][Full Text] [Related]
2. [CCAFU Recommendations 2013: Testicular germ cell cancer].
Durand X; Rigaud J; Avancès C; Camparo P; Fléchon A; Murez T; Sèbe P; Culine S; Iborra F; Mottet N; Coloby P; Soulié M;
Prog Urol; 2013 Nov; 23 Suppl 2():S145-60. PubMed ID: 24485289
[TBL] [Abstract][Full Text] [Related]
3. [CCAFU french national guidelines 2016-2018 on testicular germ cell tumors].
Durand X; Fléchon A; Murez T; Rocher L; Camparo P; Morel-Journel N; Savoie PH; Ferretti L; Sèbe P; Méjean A
Prog Urol; 2016 Nov; 27 Suppl 1():S147-S165. PubMed ID: 27846929
[TBL] [Abstract][Full Text] [Related]
4. Testicular carcinoma.
O'Callaghan A; Mead GM
Postgrad Med J; 1997 Aug; 73(862):481-6. PubMed ID: 9307739
[TBL] [Abstract][Full Text] [Related]
5. [The role of tumour markers in diagnosis and management of testicular germ cell tumours].
Krege S; Albers P; Heidenreich A
Urologe A; 2011 Mar; 50(3):313-21. PubMed ID: 21327901
[TBL] [Abstract][Full Text] [Related]
6. Testicular cancer. Clinical practice guidelines in oncology.
Motzer RJ; Bolger GB; Boston B; Carducci MA; Fishman M; Hancock SL; Hauke RJ; Hudes GR; Jonasch E; Kantoff P; Kuzel TM; Lange PH; Levine EG; Logothetis C; Margolin KA; Pohar KS; Redman BG; Robertson CN; Samlowski WE; Sheinfeld J;
J Natl Compr Canc Netw; 2006 Nov; 4(10):1038-58. PubMed ID: 17112452
[No Abstract] [Full Text] [Related]
7. Imaging of testicular germ cell tumours.
Dalal PU; Sohaib SA; Huddart R
Cancer Imaging; 2006 Sep; 6(1):124-34. PubMed ID: 16966068
[TBL] [Abstract][Full Text] [Related]
8. Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review.
Chakiryan NH; Dahmen A; Cucchiara V; Briganti A; Montorsi F; Salonia A; Spiess PE; Necchi A
J Urol; 2021 Jun; 205(6):1569-1576. PubMed ID: 33617328
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as Biomarkers for Germ Cell Tumors.
Nappi L; Nichols C
Urol Clin North Am; 2019 Aug; 46(3):449-457. PubMed ID: 31277739
[TBL] [Abstract][Full Text] [Related]
10. Surveillance in testicular cancer: who, when, what and how?
Sohaib SA; Husband J
Cancer Imaging; 2007 Oct; 7(1):145-7. PubMed ID: 17964956
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic parameters and their value in testicular tumors].
Bürgler W; Jaeger P
Urologe A; 1986 May; 25(3):157-9. PubMed ID: 3016965
[TBL] [Abstract][Full Text] [Related]
12. [Clinical presentation of testicular germinal cancer].
Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
[TBL] [Abstract][Full Text] [Related]
13. [Testicular germ-cell tumour: diagnosis and treatment].
Houlgatte A; Bauduceau O
Ann Urol (Paris); 2005 Oct; 39(5):159-69. PubMed ID: 16370168
[TBL] [Abstract][Full Text] [Related]
14. Active surveillance for stage I non-seminomatous germ cell testis tumors: practice and pitfalls.
Raghavan D; Boyer M
Prog Clin Biol Res; 1990; 350():309-18. PubMed ID: 2166960
[No Abstract] [Full Text] [Related]
15. Prognostic factors in metastatic disease.
Droz JP; Kramar A; Rey A
Semin Oncol; 1992 Apr; 19(2):181-9. PubMed ID: 1372760
[No Abstract] [Full Text] [Related]
16. Surveillance for stage I non-seminomatous germ cell tumours of the testis: the optimal protocol has not yet been defined.
Raghavan D; Colls B; Levi J; Fitzharris B; Tattersall MH; Atkinson C; Woods R; Coorey G; Farrell C; Wines R
Br J Urol; 1988 Jun; 61(6):522-6. PubMed ID: 2840997
[TBL] [Abstract][Full Text] [Related]
17. Early detection of relapse after treatment for metastatic germ cell tumour of the testis: an exercise in medical audit.
Rathmell AJ; Brand IR; Carey BM; Jones WG
Clin Oncol (R Coll Radiol); 1993; 5(1):34-8. PubMed ID: 7678749
[TBL] [Abstract][Full Text] [Related]
18. Clinical examination does not assist in the detection of systemic relapse of testicular germ cell tumour.
Cunniffe NG; Robson J; Mazhar D; Williams MV
Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):39-42. PubMed ID: 21723715
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center.
Nicolai N; Tarabelloni N; Gasperoni F; Catanzaro M; Stagni S; Torelli T; Tesone A; Bettin L; Necchi A; Giannatempo P; Raggi D; Colecchia M; Piva L; Salvioni R; Paganoni AM; Pizzocaro G; Biasoni D
J Urol; 2018 Mar; 199(3):741-747. PubMed ID: 28964782
[TBL] [Abstract][Full Text] [Related]
20. Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series.
Anheuser P; Radtke A; Wülfing C; Kranz J; Belge G; Dieckmann KP
Urol Int; 2017; 99(1):98-103. PubMed ID: 28586780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
